Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Thomas Scott

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Stem Cells Translational Medicine|October 10, 2014
Wrongful termination: lessons from the Geron clinical trialChristopher Thomas Scott, David Magnus
Nature Biotechnology|March 9, 2007
Overhauling clinical trialsChristopher Thomas Scott, Monya Baker
Nature Biotechnology|January 10, 2009
Stem cell transplants: the power of peer-to-peerGraham Creasy, Christopher Thomas Scott
The American Journal of Bioethics : AJOB|December 26, 2022
How Ethics Can Better Anticipate the Consequences of Emerging BiotechnologiesChristopher Thomas Scott, Dorit Barlevy
Stem Cell Reviews and Reports|January 9, 2010
The practical consequences of a national human embryonic stem cell registryKenneth Taymor, Christopher Thomas Scott
Nature Biotechnology|February 7, 2015
Corrigendum: Selling long lifeChristopher Thomas Scott, Laura DeFrancesco
Nature Biotechnology|June 10, 2016
Gene therapy's out-of-body experienceChristopher Thomas Scott, Laura DeFrancesco
Nature Biotechnology|January 10, 2015
Selling long lifeChristopher Thomas Scott, Laura DeFrancesco
The American Journal of Bioethics : AJOB|March 22, 2019
What to Expect When Expecting CRISPR Baby Number FourChristopher Thomas Scott, Cynthia Selin
Cell Stem Cell|May 11, 2015
Stem cell patents after the america invents actJacob S Sherkow, Christopher Thomas Scott
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Stem Cells Translational Medicine|October 10, 2014
Wrongful termination: lessons from the Geron clinical trialChristopher Thomas Scott, David Magnus
Nature Biotechnology|March 9, 2007
Overhauling clinical trialsChristopher Thomas Scott, Monya Baker
Nature Biotechnology|January 10, 2009
Stem cell transplants: the power of peer-to-peerGraham Creasy, Christopher Thomas Scott
The American Journal of Bioethics : AJOB|December 26, 2022
How Ethics Can Better Anticipate the Consequences of Emerging BiotechnologiesChristopher Thomas Scott, Dorit Barlevy
Stem Cell Reviews and Reports|January 9, 2010
The practical consequences of a national human embryonic stem cell registryKenneth Taymor, Christopher Thomas Scott
Nature Biotechnology|February 7, 2015
Corrigendum: Selling long lifeChristopher Thomas Scott, Laura DeFrancesco
Nature Biotechnology|June 10, 2016
Gene therapy's out-of-body experienceChristopher Thomas Scott, Laura DeFrancesco
Nature Biotechnology|January 10, 2015
Selling long lifeChristopher Thomas Scott, Laura DeFrancesco
The American Journal of Bioethics : AJOB|March 22, 2019
What to Expect When Expecting CRISPR Baby Number FourChristopher Thomas Scott, Cynthia Selin
Cell Stem Cell|May 11, 2015
Stem cell patents after the america invents actJacob S Sherkow, Christopher Thomas Scott
Pageof 6